Despite the roll out of free life prolonging HIV and AIDS drugs in many public clinics in Zambia and the well documented effects of Anti Retrovirals (ARVs) in reducing mortality among people living with HIV, some people living with HIV still abandon treatment. This study explores patient-related factors that influence adherence to the life prolonging drugs. It is hoped that such information would be useful in enhancing adherence so as to achieve the goal of ART. This information is critical considering irrefutable evidence that non-adherence to Anti-Retroviral Therapy (ART) can lead to drug resistance and consequently, transmission of drug resistant HIV. Drug resistant HIV is not only expensive to handle, but can lead to increased morbidity, mortality and increased incidence of HIV cases particularly, for a low income country like Zambia. Methods: This paper uses data from a large mixed method study which was conducted in a rural setting. The study explored how patient-related factors influence people living with HIV in continuing taking of medication. The paper, therefore, discusses the major reasons reported by HIV infected people on ART for either being able to consistently take their medication or failing to do so. Results: Both limiting and facilitating factors were identified as influencing adherence. Among the facilitators identified were one having a reminder, feeling better after being on ART, seeing someone on ART recover, desire to live longer and disclosure of one’s positive status. The limiting factors included forgetting to take medication, non-recovery while on treatment for some time and drug fatigue. A significant association was found between adherence treatment and one having a reminder, desire to live longer and seeing someone on ART get better. Conclusion: While facilitators enhanced adherence, the barriers prevented or discouraged people on ART from continuing taking AIDS medicines as prescribed by their health care providers. In order to avoid drug resistance and other public health implications, such as transmission of drug resistant HIV virus and deaths, there is need to address these patient-related barriers.
References
[1]
UNAIDS (2010) The Report on the Global AIDS Epidemic.
[2]
Fox, M.A., Mazumba, P.D., Seidnberg, I., Crooks, D., Sikateyo, B. and Rosen, S. (2010) Barriers to Initiation of ART in Rural and Urban Areas of Zambia: A Cross-Sectoral Study of Cost, Stigma and Perceptions of ART. Journal of the International AIDS Society, 13, 8. https://doi.org/10.1186/1758-2652-13-8
[3]
Munk, K. (1997) Traditional Health; Traditional Hospitals and HIV and AIDS: A Case Study in KwaZulu-Natal. AIDS Analysis Africa, 7, 10-12.
[4]
Christofides, N. and Jewkes, R. (2010) Acceptability of Universal Screening for Intimate Partner Violence in Voluntary HIV Testing and Counselling Services in South Africa and Service Implications. AIDS Care, 22, 279-285.
https://doi.org/10.1080/09540120903193617
[5]
Roura, M., Urassa, M. and Busza, J. (2008) Scaling up Stigma? The Effects of Antiretroviral Roll-Out on Stigma and HIV Testing: Early Evidence from Rural Tanzania, Sex Transmission Infection. https://doi.org/10.1136/sti.2008.033183
[6]
Ntalasha, H., Malungo, J.R.S., Merten, S. and Simona, S.J. (2015) The Influence of Food on HIV Testing and Adherence to Treatment in a Resource-Poor Setting, a Case of Chivuna Southern Province. Science Journal of Public Health, 3, 314-320.
https://doi.org/10.11648/j.sjph.20150303.13
[7]
Ntalasha, H. and Malungo, J.R.S. (2013) Coping Mechanisms to Barriers of Antiretroviral Therapy in a Rural Setting of Zambia: A Case of Chivuna. Zango: Zambian Journal of Contemporary Issues, Vol. 30.
[8]
Wu, Z., Zhao, Y., Chunging, L. and Detels, R. (2007) Using Case Vignettes to Measure HIV-Related Stigma among Health Professional in China. International Journal of Epidemiology, 36, 178-184. https://doi.org/10.1093/ije/dyl256
[9]
Sandlelowski, M., Lambe, C. and Borroso, J. (2004) Stigma in HIV Positive Women. Journal of Nursing Scholarship, 36, 122-128.
https://doi.org/10.1111/j.1547-5069.2004.04024.x
[10]
Schuster, M.A., Collins, R., Cunninham, W.E., Morton, S., Zierler, S., Wong, M. and Kanouse, D.E. (2005) Perceived Discrimination in Clinical Care in Nationally Representative Sample of HIV Infected Adults Receiving Health Care. Journal of General Internal Medicine, 20, 807-812.
https://doi.org/10.1111/j.1525-1497.2005.05049.x
[11]
Bangsberge, D.R.S., et al. (2003) High Levels of Adherence Do Not Prevent Accumulation of HIV Drug Resistance Mutations. AIDS, 17, 1925-1932.
https://doi.org/10.1097/00002030-200309050-00011
[12]
Ferro, E.G. and Weikum, D. (2015) Alcohol Use Disorders Negatively Influence Entire Medication Adherence among Men Who Have Sex with Men in Peru. AIDS, 27, 93-104. https://doi.org/10.1080/09540121.2014.963013
[13]
Kalichman, S. and Simbayi, L. (2003) HIV Testing Attitudes, AIDS Stigma and Voluntary HIV Counselling and Testing in a Black Township in Capetown, South Africa. Sexually Transmitted Infections, 79, 442-447.
https://doi.org/10.1136/sti.79.6.442
[14]
Meiberg, A.E., Bos, A.E.R., Onya, H.E. and Schaalma, H.P. (2008) Fear of Stigmatisation as Barrier to Voluntary HIV Counseling and Testing in South Africa. East Africa Journal of Public Health, 5, 49-53.
[15]
UNAIDS (2012) The Report on the Global AIDS Epidemic.
[16]
Chesney, M., Morin, M. and Sherr, L. (2000) Adherence to HIV Combination Therapy. Social Science and Medicine, 50, 1599-1605.
https://doi.org/10.1016/S0277-9536(99)00468-2
[17]
Carlucci, J.G., Kamanga, A., Sheneberger, R., Jenkins, C.A., Spurrier, J. and Vermund, S.H. (2008) Predictors of Adherence to ART in Rural Zambia. Journal of Acquired Immune, Deficiency Syndrome, 47, 228-230.
https://doi.org/10.1097/QAI.0b013e318165dc25
[18]
Chesney, M.A., Hecht, F.M., Sikipa, G. and Rabkin, J. (1999) Adherence: A Necessity for Successful HIV Combination Therapy. TB Clinic Based DOT Model for the Delivery of HAART. AIDS, 13, 5271-5278.
[19]
Grant, E., Logre, D., Gorman, D. and Murray, S.A. (2008) Factors Facilitating and Challenging Access and Adherence to Antiretroviral Therapy in a Township in the Zambian Copper-Belt Province: A Qualitative Study. AIDS Care, 20, 1155-1159.
https://doi.org/10.1080/09540120701854634
[20]
Ministry of Health (2012) Zambia Country Report, Lusaka, Zambia.
[21]
Barfod, T.S., Sorensen, H.T., Niesen, H., Rodkjoer, L. and Obel, N. (2006) Simply Forget Is the Most Common Frequently Stated Reason for Missed Doses of HAART Irrespective of Degree ODF Adherence, British HIV Association. HIV Medicine, 7, 285-290. https://doi.org/10.1111/j.1468-1293.2006.00387.x
[22]
Schumaker, L.L. and Bond, V. (2008) Antiretroviral Therapy in Zambia: Colours Spoiling Talk and the Meaning of Antiretrovirals. Social Science and Medicine, 67, 2121-2134. https://doi.org/10.1016/j.socscimed.2008.09.006
[23]
Hardon, A.P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H.F., Gerrits, T., Kglatwane, J., Kinsman, J., Kwasa, R., Maridadi, J., Moroka, T.M., Moyo, S., Nakiyemba, A., Nsimba, S., Ogenyi, R., Oyabba, T., Temu, F. and Laing, R. (2007) Hunger, Waiting Times and Transport Costs: Time to Confront Challenges to ART Adherence in Africa. AIDS Care, 19, 658-665. https://doi.org/10.1080/09540120701244943
[24]
Merten, S., Kenter, E., Mckenzie, O., Musheke, M., Ntalasha, H. and Martin-Hilber, A. (2010) Patient-Reported Barriers and Drivers of Adherence to Antiretrovirals in Sub-Saharan Africa: A Meta-Enthnography. Tropical Medicine and International Health, 15, 1-18. https://doi.org/10.1111/j.1365-3156.2010.02510.x
[25]
Murray, L.K., Semrau, E., McCurley, D.M., et al. (2009) Barriers to Acceptance and Adherence of Antiretroviral Therapy in Urban Zambian Women: A Qualitative Study. AIDS Care, 21, 78-86. https://doi.org/10.1080/09540120802032643
[26]
Grant, E., Logre, D., Gorman, D. and Murray, S.A. (2008) Factors Facilitating and Challenging Access and Adherence to Antiretroviral Therapy in a Township in the Zambian Copper-Belt Province: A Qualitative Study. AIDS Care, 20, 1155-1159.
https://doi.org/10.1080/09540120701854634
[27]
Musheke, M., Ntalasha, H., Gari, S., Mckanzie, O., Bond, V., Martin-Hilber, A. and Merten, S. (2013) A Systematic Review of Qualitative Findings on Factors Enabling and Deterring Uptake of HIV Testing in Sub-Saharan Africa. BMC Public Health, 13, 220. https://doi.org/10.1186/1471-2458-13-220
[28]
Nuwaha, F., Kabatesi, D., Whalen, C.C. and Muganwa, M. (2002) Factors Influencing Acceptability of Voluntary Counselling and Testing for HIV in Bushenyi District of Uganda. East African Medical Journal, 79, 626-632.
https://doi.org/10.4314/eamj.v79i12.8669
[29]
Unge, C., Johansson, A.R., Zachariah, D. and Engelgem, I.V. (2008) Reasons for Unsatisfactory Acceptance of Antiretroviral Treatment in the Urban Kibera Slum, Kenya. AIDS Care, 20, 146-149. https://doi.org/10.1080/09540120701513677
[30]
Ware, N.C., Idoko, J., Kaaya, S., Binaro, I.A., et al. (2009) Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study. PLOS Medicine, 6, e11.
http://www.plosmedicine.org
https://doi.org/10.1371/journal.pmed.1000011
[31]
Weiser, S., Wolfe, W., Bangsberge, D.R., Gilbert, P., MaKhema, J., Kebaabetswe, P., Dickenson, D., Kgosidialwa, M. and Marlink, R. (2003) Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes, 34, 281-288.
https://doi.org/10.1097/00126334-200311010-00004
[32]
WHO (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treatment and Prevention of HIV Infection: Recommendation for a Public Approach. Geneva.
[33]
Nachega, J.B., Knowlton, A.R., Deluca, A., Schoeman, J.H., Watkinson, L., Efron, A., Chaisson, R.E. and Maartens, G. (2006) Adherence to Antiretroviral Therapy in HIV Infected South African Adults, Stigma, Alcohol Abuse, Lack of Financial Resources and Food and Treatment Supporters to Improve Adherence. Acquired Immune Deficiency Syndrome, 43, 5127-5132.
https://doi.org/10.1097/01.qai.0000248349.25630.3d
[34]
Layer, E.H., Kennedy, C.E., Beckham, S.W., Mbwambo, J.K., Likindikoki, S., et al. (2014) Multi-Level Factors Affecting Entry into and Engagement in the HIV Continuum of Care in Iringa, Tanzania. PLoS ONE, 9, e104961.
https://doi.org/10.1371/journal.pone.0104961
